Delivery Order SPE2DB20D3103-SPE2DB23FN4L8
Award Date 5/18/23
Potential Completion Date 5/19/23
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB20D3103|SPE2DB21FQ3A7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $85,933.54 Firm Fixed Price delivery order is for the supply of 4,554,798,447 units of the pharmaceutical drug Capecitabine 500 mg Tablets. The contract has no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,115.50 fixed-price contract is for the supply of 120 tablets of the medication Capecitabine 500 mg. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, valued at $1,124.64. This is a firm fixed-price, non-set-aside contract with a completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency has awarded a $1,234.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Capecitabine 500 mg, with an ultimate completion date of February 2, 2026. This non-set-aside award was issued on January 30, 2026, and will be performed at the vendor's location in Conshohocken, Pennsylvania. Capecitabine is an oral chemotherapy medication commonly used in cancer treatment, and this delivery order represents a specific task order executed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of Acamprosate Calcium DR 333 mg tablets, with a period of performance through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of medical products including tablets, capsules, and other pharmaceutical items. The contract, valued at $6,643.79, is a Firm Fixed Price Delivery Order with a completion date of May 3, 2023. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB22FH2A0) valued at $1,493.20 for the supply of 4555553872 MERCAPTOPURINE 50 MG TABLET 250S. The contract was awarded on November 30, 2021, with a completion date of December 1, 2021. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide pharmaceutical products and medical supplies. The contract, valued at $7,488.80, is a delivery order for the medication Ibrance 100 mg capsule. The contract has an ultimate completion date of December 27, 2023 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,306.24, covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $559,691.15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. Amerisourcebergen Drug Corp is a...